Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Survey: Parents Increasingly Ask Doctors to Delay Vaccines

March 2, 2015 12:29 pm | by Lindsey Tanner, AP Medical Writer | News | Comments

Parents have increasingly pressured doctors to delay vaccines for young children, making their kids and others vulnerable to preventable diseases. Read more...                 

TOPICS:

Firm Agrees to Refund to Settle Suit Over Weight-Loss Pills

March 2, 2015 12:23 pm | by Associated Press | News | Comments

Salt Lake City-based company has agreed to pay refunds to consumers who purchased its weight-loss tablets to settle a class-action lawsuit. Read more...                  

TOPICS:

New Target Identified in Fight Against Alzheimer's, Multiple Sclerosis

March 2, 2015 10:15 am | News | Comments

Highlighting a potential target in the treatment of multiple sclerosis (MS) and Alzheimer's disease, new research suggests that triggering a protein found on the surface of brain cells may help slow the progression of these and other neurological diseases.

TOPICS:
Advertisement

How An FDA-Approved Drug Boosts Myelin Synthesis

March 2, 2015 10:11 am | News | Comments

Damage to myelin, the fatty insulator that enables communication between nerve cells, characterizes multiple sclerosis (MS) and other devastating neurological diseases. Read more...

TOPICS:

FDA Approves Actavis', Medicines360's Long-Term Contraception

March 2, 2015 10:06 am | News | Comments

Actavis plc, a leading global specialty pharmaceutical company, and Medicines360, a nonprofit women's health pharmaceutical company, announced the approval of Liletta (levonorgestrel-releasing intrauterine system) by the U.S. Food and Drug Administration (FDA) for use by women to prevent pregnancy for up to three years. Read more...

TOPICS:

Mylan Completes Acquisition Of Abbott's Non-U.S. Developed Markets

March 2, 2015 9:58 am | News | Comments

​Mylan N.V. and Mylan Inc. announced the successful completion of the acquisition of Abbott Laboratories' (NYSE: ABT) non-U.S. developed markets specialty and branded generics business. Read more..

TOPICS:

First Treatment Approved in Canada for Adults With ADPKD

March 2, 2015 9:52 am | News | Comments

Otsuka Pharmaceutical Co., Ltd. and its affiliate Otsuka Canada Pharmaceutical Inc. announce that Health Canada has approved JINARC (tolvaptan) as the first pharmaceutical agent for the treatment of autosomal dominant polycystic kidney disease (ADPKD). Read more...

TOPICS:

Sierra Leone's Vice President In Quarantine for Ebola

March 2, 2015 9:36 am | by Clarence Roy-Macaulay, Associated Press | News | Comments

Sierra Leone's vice president has put himself in quarantine following the death from Ebola of one of his security guards. Read more...                                   

TOPICS:
Advertisement

Lyric Pharmaceuticals: $20.4M Series A Funding Round

February 27, 2015 1:41 pm | News | Comments

Lyric Pharmaceuticals Inc. today announced the initial closing of a Series A financing round totaling $20.4 million. Read more...                                     

TOPICS:

Former Sanofi CEO Joins Puretech’s Board of Directors

February 27, 2015 1:29 pm | News | Comments

PureTech, a science and technology R&D company focused  on identifying, inventing and commercializing disruptive products and technologies in the healthcare sector, announced today the appointment of Christopher Viehbacher, former CEO and Member of the Board of Directors of Sanofi, to its Board of Directors.  Read more...

TOPICS:

TSRI Team Shows How Rare Antibody Targets Ebola, Marburg Viruses

February 27, 2015 1:20 pm | by Scripps Research Institute | News | Comments

Marburg virus is Ebola’s deadly cousin. The virus is up to 90 percent lethal—and doctors are desperate for tools to fight it. Read more...

TOPICS:

Making Proactive Asset Management Work for Business

February 27, 2015 1:02 pm | by Ben Potenza, VP Marketing, EquipNet | Articles | Comments

Millions are spent every year on the laboratory equipment and instrumentation that is essential for the daily work of research and analysis in the pharmaceutical, biotechnology and chemical sectors. Read more...                 

TOPICS:

Panel: Use New Meningitis Vaccines Only For Outbreaks

February 27, 2015 12:58 pm | by Mike Stobbe, AP Medical Writer - Associated Press | News | Comments

A federal panel on Thursday recommended that two new meningitis vaccines only be used for rare outbreaks, resisting tearful pleas to give it routinely to teens and college students. Read more...

TOPICS:

Heat Blamed for Spray Vaccine's Failure Against Swine Flu

February 27, 2015 12:53 pm | by Mike Stobbe, AP Medical Writer - Associated Press | News | Comments

The makers of the nasal spray version of the flu vaccine say now they know why it has failed to protect young U.S. children against swine flu - fragile doses got too warm. Read more...

TOPICS:

Takeda's Treatment for Acid-Related Diseases is Now Available in Japan

February 27, 2015 9:10 am | News | Comments

This medicine treats acid-related diseases with a novel mechanism of action called potassium-competitive acid blockers. Read more...                    

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading